PEPS
MCID: EPL050
MIFTS: 25

Epilepsy, Partial, with Pericentral Spikes (PEPS)

Aliases & Classifications for Epilepsy, Partial, with Pericentral Spikes

MalaCards integrated aliases for Epilepsy, Partial, with Pericentral Spikes:

Name: Epilepsy, Partial, with Pericentral Spikes 56 13 71
Peps 56
Epps 56

External Ids:

OMIM 56 607221
UMLS 71 C1846609

Summaries for Epilepsy, Partial, with Pericentral Spikes

MalaCards based summary : Epilepsy, Partial, with Pericentral Spikes, also known as peps, is related to protoporphyria, erythropoietic, 1 and poems syndrome. An important gene associated with Epilepsy, Partial, with Pericentral Spikes is EPPS (Epilepsy, Partial, With Pericentral Spikes). The drugs Cisplatin and leucovorin have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and breast.

More information from OMIM: 607221

Related Diseases for Epilepsy, Partial, with Pericentral Spikes

Diseases related to Epilepsy, Partial, with Pericentral Spikes via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 132)
# Related Disease Score Top Affiliating Genes
1 protoporphyria, erythropoietic, 1 12.4
2 poems syndrome 11.9
3 pruritic urticarial papules and plaques of pregnancy 11.3
4 pepck 1 deficiency 11.2
5 protoporphyria, erythropoietic, 2 11.2
6 porphyria 11.2
7 cutaneous porphyria 11.2
8 cystic fibrosis 10.4
9 pulmonary embolism 10.4
10 rabies 10.3
11 benign mesothelioma 10.2
12 malignant pleural mesothelioma 10.2
13 chlamydia pneumonia 10.2
14 chlamydia 10.2
15 cerebrovascular disease 10.2
16 hypertriglyceridemia, familial 10.2
17 pulmonary disease, chronic obstructive 10.2
18 bronchitis 10.2
19 neutropenia 10.1
20 personality disorder 10.1
21 vascular disease 10.1
22 transient cerebral ischemia 10.1
23 idiopathic interstitial pneumonia 10.1
24 pulmonary fibrosis 10.1
25 liver disease 10.1
26 human immunodeficiency virus infectious disease 10.1
27 myasthenia gravis 10.1
28 polycystic kidney disease 10.1
29 acute cystitis 10.1
30 candidiasis 10.1
31 angioedema 10.1
32 vulvovaginal candidiasis 10.1
33 iron metabolism disease 10.1
34 urinary tract obstruction 10.1
35 pneumonia 10.1
36 kidney disease 10.1
37 48,xyyy 10.1
38 brain injury 10.1
39 traumatic brain injury 10.1
40 tremor 10.1
41 autoimmune disease 10.0
42 attention deficit-hyperactivity disorder 10.0
43 paroxysmal extreme pain disorder 10.0
44 autism 10.0
45 anxiety 10.0
46 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
47 gastric cancer 10.0
48 mantle cell lymphoma 10.0
49 tetanus 10.0
50 epilepsy 10.0

Graphical network of the top 20 diseases related to Epilepsy, Partial, with Pericentral Spikes:



Diseases related to Epilepsy, Partial, with Pericentral Spikes

Symptoms & Phenotypes for Epilepsy, Partial, with Pericentral Spikes

Clinical features from OMIM:

607221

Drugs & Therapeutics for Epilepsy, Partial, with Pericentral Spikes

Drugs for Epilepsy, Partial, with Pericentral Spikes (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 13)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 1 15663-27-1 84093 441203 2767
2
leucovorin Approved Phase 1 58-05-9 6006 143
3
Pemetrexed Approved, Investigational Phase 1 150399-23-8, 137281-23-3 446556 60843
4
Folic acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
5 Folic Acid Antagonists Phase 1
6 Vitamin B Complex Phase 1
7 Vitamin B9 Phase 1
8 Folate Phase 1
9 Antipsychotic Agents
10 Hemostatics
11 Fibrin fragment D
12 Coagulants
13 Antifibrinolytic Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis Withdrawn NCT01573806 Phase 1, Phase 2 Exenatide;Exenatide vehicle
2 Phase I Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for Malignant Pleural Mesotheliomas Recruiting NCT02838745 Phase 1 Pemetrexed;Cisplatin
3 Positive Emotions Program for Schizophrenia (PEPS): A Randomized Controlled Study on Improving Pleasure and Motivation in Schizophrenia Completed NCT02593058
4 Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy Completed NCT02300675
5 Proyecto ESCUDO: Police Training to Reduce Occupational Needlesticks and HIV Among Substance Users Completed NCT02444403
6 Prevention of Peritonitis in Patients With Peritoneal Dialysis - Effects of Regular Follow-up of Patients´ Theoretical Knowledge and Practical Skills With Focus on Infection Prophylaxis Completed NCT01293799
7 MOdified DIagnostic strateGy to Safely ruLe-out Pulmonary Embolism In the Emergency depArtment: A Non-Inferiority Cluster Cross-over Randomized Trial Recruiting NCT04032769

Search NIH Clinical Center for Epilepsy, Partial, with Pericentral Spikes

Genetic Tests for Epilepsy, Partial, with Pericentral Spikes

Anatomical Context for Epilepsy, Partial, with Pericentral Spikes

MalaCards organs/tissues related to Epilepsy, Partial, with Pericentral Spikes:

40
Brain, Heart, Breast, Skin, Testes, T Cells, Kidney

Publications for Epilepsy, Partial, with Pericentral Spikes

Articles related to Epilepsy, Partial, with Pericentral Spikes:

(show top 50) (show all 290)
# Title Authors PMID Year
1
Partial epilepsy with pericentral spikes: a new familial epilepsy syndrome with evidence for linkage to chromosome 4p15. 56
12112080 2002
2
Isolation and identification of polysaccharides from Pythium arrhenomanes and application to strawberry fruit (Fragaria ananassa Duch.) preservation. 61
31689590 2020
3
Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period. 61
32009515 2020
4
Danger peptide signaling enhances internalization of a geminivirus symptom determinant in plant cells during infection. 61
31990035 2020
5
Methicillin-sensitive Staphylococcusaureus bacterial endarteritis associated with vascular closure device. 61
31959652 2020
6
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study. 61
32001078 2020
7
Inhalation of printer-emitted particles impairs cardiac conduction, hemodynamics, and autonomic regulation and induces arrhythmia and electrical remodeling in rats. 61
31996220 2020
8
Integrated Transcriptomics, Metabolomics, and Lipidomics Profiling in Rat Lung, Blood, and Serum for Assessment of Laser Printer-Emitted Nanoparticle Inhalation Exposure-Induced Disease Risks. 61
31888290 2019
9
Type-II Metacaspases Mediate the Processing of Plant Elicitor Peptides in Arabidopsis. 61
31454707 2019
10
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort. 61
31746462 2019
11
High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults. 61
31455687 2019
12
Cleave and Unleash: Metacaspases Prepare Peps for Work. 61
31272898 2019
13
The feasibility and appropriateness of a peer-to-peer, play-based intervention for improving pragmatic language in children with autism spectrum disorder. 61
30175619 2019
14
Danger-Associated Peptides Interact with PIN-Dependent Local Auxin Distribution to Inhibit Root Growth in Arabidopsis. 61
31123046 2019
15
A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures. 61
31230646 2019
16
One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry. 61
31103407 2019
17
Pinprick Evoked Potentials-Reliable Acquisition in Healthy Human Volunteers. 61
31216028 2019
18
An intramembrane sensory circuit monitors sortase A-mediated processing of streptococcal adhesins. 61
31064885 2019
19
Central sensitization increases the pupil dilation elicited by mechanical pinprick stimulation. 61
30785805 2019
20
Rapid, label-free genetic detection of enteropathogens in stool without genetic isolation or amplification. 61
30731348 2019
21
The Carbon Switch at the Level of Pyruvate and Phosphoenolpyruvate in Sulfolobus solfataricus P2. 61
31031731 2019
22
Impact of Positive Emotion Regulation Training on Negative Symptoms and Social Functioning in Schizophrenia: A Field Test. 61
31404331 2019
23
Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial. 61
30783071 2019
24
Improving police conceptual knowledge of Mexico's law on cannabis possession: Findings from an assessment of a police education program. 61
30516331 2018
25
Nonlinear Emission of Molecular Ensembles Strongly Coupled to Plasmonic Lattices with Structural Imperfections. 61
30608720 2018
26
A novel and sensitive chemiluminescence immunoassay based on AuNCs@pepsin@luminol for simultaneous detection of tetrabromobisphenol A bis(2-hydroxyethyl) ether and tetrabromobisphenol A mono(hydroxyethyl) ether. 61
30224136 2018
27
In situ, amplification-free double-stranded mutation detection at 60 copies/ml with thousand-fold wild type in urine. 61
30142581 2018
28
Influence of physician evaluation portals on orthodontist selection by patients. 61
30187082 2018
29
Improvements in the water dispersibility of paclitaxel by complexing with synthetic peptides derived from β-casein. 61
29635137 2018
30
Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. 61
29767567 2018
31
The plant cell wall integrity maintenance and immune signaling systems cooperate to control stress responses in Arabidopsis thaliana. 61
29945884 2018
32
Integration of danger peptide signals with herbivore-associated molecular pattern signaling amplifies anti-herbivore defense responses in rice. 61
29513388 2018
33
Danger-Associated Peptides Close Stomata by OST1-Independent Activation of Anion Channels in Guard Cells. 61
29716993 2018
34
Differential effect of a patient-education transition intervention in adolescents with IBD vs. diabetes. 61
29340756 2018
35
Plant elicitor peptides promote plant defences against nematodes in soybean. 61
28600875 2018
36
β-Lactoglobulin Peptide Fragments Conjugated with Caffeic Acid Displaying Dual Activities for Tyrosinase Inhibition and Antioxidant Effect. 61
29533643 2018
37
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. 61
28663026 2018
38
The physical education predisposition scale: Preliminary tests of reliability and validity in Australian students. 61
28357932 2018
39
Novel Rosaceae plant elicitor peptides as sustainable tools to control Xanthomonas arboricola pv. pruni in Prunus spp. 61
28056495 2018
40
Diversity of plant defense elicitor peptides within the Rosaceae. 61
29361905 2018
41
Executive Functions and Prosodic Abilities in Children With High-Functioning Autism. 61
29618997 2018
42
Structural Characterization of Polysaccharides of a Productive Strain of the Culinary-Medicinal King Oyster Mushroom, Pleurotus eryngii (Agaricomycetes), from Italy. 61
30317948 2018
43
An innovative way to highlight the power of each polymorphism on elite athletes phenotype expression. 61
29686814 2018
44
Perturbation-evoked potentials: Significance and application in balance control research. 61
29107828 2017
45
Psychoeducation and Problem Solving (PEPS) Therapy for Adults With Personality Disorder: A Pragmatic Randomized-Controlled Trial. 61
28513346 2017
46
Synergistic effects of engineered nanoparticles and organics released from laser printers using nano-enabled toners: potential health implications from exposures to the emitted organic aerosol. 61
30197786 2017
47
Modelling gene-environment interaction in first episodes of psychosis. 61
28179063 2017
48
Comparison of perceptual eye positions among patients with different degrees of anisometropia. 61
28953639 2017
49
Relationship between pemphigus and American tegumentary leishmaniasis: insights from serological and genetic profiles. 61
29237064 2017
50
Phase-locked and non-phase-locked EEG responses to pinprick stimulation before and after experimentally-induced secondary hyperalgesia. 61
28618295 2017

Variations for Epilepsy, Partial, with Pericentral Spikes

Expression for Epilepsy, Partial, with Pericentral Spikes

Search GEO for disease gene expression data for Epilepsy, Partial, with Pericentral Spikes.

Pathways for Epilepsy, Partial, with Pericentral Spikes

GO Terms for Epilepsy, Partial, with Pericentral Spikes

Sources for Epilepsy, Partial, with Pericentral Spikes

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....